Literature DB >> 17289037

Transformation of the proteasome with age-related macular degeneration.

Cheryl M Ethen1, Stacy A Hussong, Cavan Reilly, Xiao Feng, Timothy W Olsen, Deborah A Ferrington.   

Abstract

The proteasome mediates pathways associated with oxidative stress and inflammation, two pathogenic events correlated with age-related macular degeneration (AMD). In human donor eyes corresponding to four stages of AMD, we found the proteasomal chymotrypsin-like activity increased in neurosensory retina with disease progression. Increased activity correlated with a dramatic increase in the inducible subunits of the immunoproteasome, which was not due to an increase in CD45 positive immune cells in the retina. The novel observation of proteasome transformation may reflect retinal response to local inflammation or oxidative stress with AMD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289037      PMCID: PMC1850528          DOI: 10.1016/j.febslet.2007.01.061

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

1.  Selective degradation of oxidized calmodulin by the 20 S proteasome.

Authors:  D A Ferrington; H Sun; K K Murray; J Costa; T D Williams; D J Bigelow; T C Squier
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

2.  Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.

Authors:  John W Crabb; Masaru Miyagi; Xiaorong Gu; Karen Shadrach; Karen A West; Hirokazu Sakaguchi; Motohiro Kamei; Azeem Hasan; Lin Yan; Mary E Rayborn; Robert G Salomon; Joe G Hollyfield
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

Review 3.  Impairment of proteasome structure and function in aging.

Authors:  Géraldine Carrard; Anne-Laure Bulteau; Isabelle Petropoulos; Bertrand Friguet
Journal:  Int J Biochem Cell Biol       Date:  2002-11       Impact factor: 5.085

Review 4.  The role of inflammation in the pathogenesis of age-related macular degeneration.

Authors:  Larry A Donoso; David Kim; Arcilee Frost; Alston Callahan; Gregory Hageman
Journal:  Surv Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 6.048

Review 5.  Age-related macular degeneration (AMD): pathogenesis and therapy.

Authors:  Jerzy Z Nowak
Journal:  Pharmacol Rep       Date:  2006 May-Jun       Impact factor: 3.024

6.  The proteome of central and peripheral retina with progression of age-related macular degeneration.

Authors:  Cheryl M Ethen; Cavan Reilly; Xiao Feng; Timothy W Olsen; Deborah A Ferrington
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

7.  LMP2 knock-out mice have reduced proteasome activities and increased levels of oxidatively damaged proteins.

Authors:  Qunxing Ding; Sarah Martin; Edgardo Dimayuga; Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  Antioxid Redox Signal       Date:  2006 Jan-Feb       Impact factor: 8.401

8.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.

Authors:  Gregory S Hageman; Don H Anderson; Lincoln V Johnson; Lisa S Hancox; Andrew J Taiber; Lisa I Hardisty; Jill L Hageman; Heather A Stockman; James D Borchardt; Karen M Gehrs; Richard J H Smith; Giuliana Silvestri; Stephen R Russell; Caroline C W Klaver; Irene Barbazetto; Stanley Chang; Lawrence A Yannuzzi; Gaetano R Barile; John C Merriam; R Theodore Smith; Adam K Olsh; Julie Bergeron; Jana Zernant; Joanna E Merriam; Bert Gold; Michael Dean; Rando Allikmets
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

Review 9.  The role of oxidative stress in the pathogenesis of age-related macular degeneration.

Authors:  S Beatty; H Koh; M Phil; D Henson; M Boulton
Journal:  Surv Ophthalmol       Date:  2000 Sep-Oct       Impact factor: 6.048

10.  Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells.

Authors:  Srigiridhar Kotamraju; Sadis Matalon; Toshiyuki Matsunaga; Tiesong Shang; J M Hickman-Davis; B Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2005-11-17       Impact factor: 7.376

View more
  43 in total

Review 1.  Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration.

Authors:  Fu Shang; Allen Taylor
Journal:  Mol Aspects Med       Date:  2012-04-10

2.  Immunoproteasome deficiency alters retinal proteasome's response to stress.

Authors:  Stacy A Hussong; Rebecca J Kapphahn; Stacia L Phillips; Marcela Maldonado; Deborah A Ferrington
Journal:  J Neurochem       Date:  2010-03-14       Impact factor: 5.372

3.  Effect of ubiquitination on peptidase activities of proteasomes in genotoxic stress.

Authors:  T N Moiseeva; O A Fedorova; A S Tsimokha; A G Mittenberg; N A Barlev
Journal:  Dokl Biochem Biophys       Date:  2010-12-24       Impact factor: 0.788

4.  A novel role for the immunoproteasome in retinal function.

Authors:  Stacy A Hussong; Heidi Roehrich; Rebecca J Kapphahn; Marcela Maldonado; Machelle T Pardue; Deborah A Ferrington
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-09       Impact factor: 4.799

Review 5.  Degradation of damaged proteins: the main function of the 20S proteasome.

Authors:  Andrew M Pickering; Kelvin J A Davies
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 6.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

7.  Immunoproteasome responds to injury in the retina and brain.

Authors:  Deborah A Ferrington; Stacy A Hussong; Heidi Roehrich; Rebecca J Kapphahn; Shannon M Kavanaugh; Neal D Heuss; Dale S Gregerson
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

8.  Syrbactin Structural Analog TIR-199 Blocks Proteasome Activity and Induces Tumor Cell Death.

Authors:  André S Bachmann; John Opoku-Ansah; Tannya R Ibarra-Rivera; Lisette P Yco; Sudhakar Ambadi; Christopher C Roberts; Chia-En A Chang; Michael C Pirrung
Journal:  J Biol Chem       Date:  2016-02-23       Impact factor: 5.157

9.  Immunoproteasome in animal models of Duchenne muscular dystrophy.

Authors:  Chiao-Nan Joyce Chen; Ted G Graber; Wendy M Bratten; Deborah A Ferrington; LaDora V Thompson
Journal:  J Muscle Res Cell Motil       Date:  2014-06-17       Impact factor: 2.698

10.  Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors.

Authors:  Deborah J Kuhn; Sally A Hunsucker; Qing Chen; Peter M Voorhees; Marian Orlowski; Robert Z Orlowski
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.